↓ Skip to main content

Oncotarget

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas

Overview of attention for article published in Oncotarget, February 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
33 Mendeley